Having trouble accessing articles? Reset your cache.

Tenofovir 1% vaginal gel: Phase IIb data

Researchers at the Centre for the AIDS Program of Research in South Africa (CAPRISA) and colleagues reported data from the double-blind, South African Phase IIb

Read the full 256 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE